Ignite Creation Date:
2025-12-24 @ 6:27 PM
Ignite Modification Date:
2026-01-02 @ 2:18 AM
Study NCT ID:
NCT01693068
Status:
COMPLETED
Last Update Posted:
2018-01-05
First Post:
2012-09-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Sponsor:
EMD Serono
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma | View |